There is no routine registration of the occurrence of newly diagnosed cases of cirrhosis in the United Kingdom. This study seeks to determine precise estimates and trends of the incidence of cirrhosis in England, and directly compare these fi gures with those for the 20 most commonly diagnosed cancers in the United Kingdom.
INTRODUCTION
In her most recent report, the Chief Medical Offi cer of the United Kingdom has highlighted liver disease as the only major cause of mortality and morbidity that is rising in England ( 1 ) . However, in contrast to other chronic diseases with similar spectra of etiology and survival such as cancer, where national registries have been collecting data for over 80 years ( 2 ) , the United Kingdom currently has no registry to monitor the occurrence of newly diagnosed cases of cirrhosis. Th e assessment of the health-care burden of liver disease remains reliant on mortality statistics ( 3, 4 ) . Th e use of mortality data to monitor trends in incidence of liver disease, and in particular cirrhosis, is inadequate as these fi gures do not refl ect the present day burden of a disease, as not all patients with cirrhosis will die as a direct result of their liver disease, particularly those with compensated disease.
Previous population-based studies looking at cirrhosis have used records from either primary care (i.e., general / family practitioners) or secondary care (inpatient hospitalizations) in isolation to estimate the occurrence of cirrhosis in the United Kingdom ( 5 -7 ) . Our previous work is an example of a study where primary-care data alone were used as hospital registry data, at the time of the study, were unavailable. Limiting data to just one source inevitably results in a selected population of either principally ambulatory people or patients with decompensated disease, and consequently under-or overestimates the occurrence of disease. Now, for the fi rst time, through the relatively recent linkage of primary-and secondary-care data in England, we have established a comprehensive population-based cohort that is representative of the whole population of people with cirrhosis from which incidence rates can be estimated more precisely than before.
Cirrhosis, like cancer, is oft en preventable, can be detected early and has a high mortality rate. If trends in disease can be adequately monitored, as in the case of cancer, some patients can be diagnosed earlier and provided with appropriate treatments and / or interventions to improve modifi able lifestyle factors. By comparing the occurrence of cirrhosis systematically with that of the top 20 diagnosed cancers in the United Kingdom, our study puts a context to the burden of cirrhosis.
Th e aim of this study is to establish a comprehensive and wellvalidated study population of patients with cirrhosis to determine precise estimates of the incidence in England, the rate of change in incidence and to directly compare these fi gures with those for the 20 most commonly diagnosed cancers in the United Kingdom.
METHODS

Study design
We used population-based routinely collected electronic healthcare data from primary-and secondary-care registries in England to identify incident cases of cirrhosis.
Primary-care data
Primary care in the United Kingdom consists of care provided in a community setting through general or family practitioners. Th e Clinical Practice Research Datalink (CPRD) is a longitudinal electronic database consisting of anonymized primary-care records of over 10 million patients in the United Kingdom, collected since 1987. Th e data are coded using the Read code system ( 8 ). Participating practices are assigned an up to standard date on completion of regular audits confi rming data quality and completeness; patient-level data are also assessed ( 9 ) . Th e CPRD has previously been shown to be representative of the population of the United Kingdom ( 10 ) . Th e data within CPRD consists of records of clinical diagnoses, treatments, and outcomes of patients seen while ambulatory including information from referral letters and diagnoses made by consultants in an outpatient setting.
Secondary-care data
Secondary care in the United Kingdom consists of care provided in a hospital setting. Th e Hospital Episodes Statistics (HES) database comprises statutory records of all hospital admissions (excluding outpatients) conducted in NHS hospitals and independent treatment centres in England, since 1989. For each period of time under the care of a consultant, a patient is assigned a primary diagnosis and up to 19 secondary diagnoses, coded using the ICD10 (International Classifi cation of Diseases, tenth revision), and / or up to 24 recorded procedures coded using the OPCS4 (Offi ce of Population, Censuses and Surveys ' classifi cation of surgical operations and procedures, fourth revision). We accessed data for patients registered at CPRD practices in England that have given consent to be linked to the HES database.
Death registry data
Th e Offi ce for National Statistics (ONS) provides death registry data for CPRD practices that are linked to the HES.
Study population
We had access to data from all 244 Table 2 ). Patients were considered to have cirrhosis if they had one or more of these codes in their records. We excluded patients who had a record of cancer and an isolated procedure relating to ascites and no other evidence or death related to liver disease.
Observation period
Th e observation period commenced on the latest of (i) 1 year aft er the patient ' s current registration date or (ii) the practice ' s up to standard date. Th e 1-year cutoff was used to avoid including potential prevalent cases, adapted from Lewis et al. ' s methodology ( 11 ) . Th e period terminated on the earliest of (i) date of death, (ii) date the patient left the practice, or (iii) the practice ' s last data collection date. Incident diagnoses were identifi ed between 1 January 1998 and 31 December 2009.
Validation of case defi nition
For people with a cirrhosis diagnosis recorded in primary care, we established how many had a hospital admission related to liver disease (e.g., alcoholic liver disease or chronic hepatitis).
For patients identifi ed with cirrhosis from secondary-care records only, we searched in both their primary-and secondarycare records and ONS death registry data for codes related to liver disease. We examined their primary-care free text data for any of the following terms: " cirrhosis " , " ascites " , " varices " , " liver " , " portal hypertension " , " hepatic " , " jaundice " , or " paracentesis " .
Diagnosis date
For each patient, we assigned the date of diagnosis as the fi rst date associated with a Read or ICD10 / OPCS4 code for cirrhosis within the observation period. Patients younger than 18 years at diagnosis were excluded.
Etiology
We searched the patient ' s medical records for evidence of viral hepatitis, autoimmune, and metabolic diseases. We defi ned patients as having an underlying alcoholic etiology if there was any mention in their primary-or secondary-care records of alcoholism, alcohol abuse, addiction, or dependence, " problem drinking " or referral to alcohol cessation services, or if their recorded weekly alcohol consumption in their primary-care records exceeded the Chief Medical Offi cer ' s recommended amount (14 units for women and 21 units for men) ( 12 ) . Our Read code list for this was adapted from previous work ( 5 ) and our ICD10 code list was adapted from the codes used by Statistics on Alcohol, England ( 13 ). Etiology was ascribed in a hierarchical manner of viral hepatitis, autoimmune, or metabolic disease and alcoholic cirrhosis. All remaining patients with no recorded etiology were defi ned as cryptogenic cirrhosis. 
Stage of disease
We defi ned stages of disease as agreed at the Baveno IV consensus conference ( 14 ) . Each of the four stages is defi ned by the presence or absence of certain clinical symptoms around the time of diagnosis. Stages 1 and 2 represent compensated cirrhosis and stages 3 and 4 decompensated cirrhosis.
Statistical analysis
We excluded patients whose date of diagnosis was concurrent with death. We used t -tests and diff erence in proportions to test for diff erences, for continuous and categorical variables, respectively. We calculated crude incidence by dividing the number of cases by the total number of person-years from the HES-linked CPRD population at risk during the incident observation period.
For each valid year, we calculated the proportion of person-years at risk excluding the fi rst year post-registration. We looked at incidence by age, sex, etiology, and year of diagnosis. We fi tted a Poisson model to determine adjusted incidence rate ratios (IRRs). Stata version 12 / MP4 (StataCorp LP, TX) was used for all statistical analyses.
Comparison with cancer
To make a comparison with the incidence of cancer, we obtained the number of new cases diagnosed in 2009 for the top 20 most diagnosed cancers from Cancer Research UK ( 15 ). To determine the percentage change in incidence over time, for each cancer, Cancer Research UK applied their age-specifi c incidence fi gures to the age-standardized European population and determined age-standardized rates per 100,000 person-years for men and women. From this they calculated the percentage change between the period 1998 -2000 and 2007 -2009. We applied the same methodology to our cirrhosis incidence fi gures to estimate the number of new cases diagnosed in 2009 in the United Kingdom (using the ONS 2009 mid-population) and the percentage change in incidence for European age-standardized rates for men and women over the same period. We added our cirrhosis fi gures to graphs provided by Cancer Research UK.
RESULTS
Study cohort
Combining 2,282 patients identifi ed in secondary care with 2,965 patients who had a diagnosis in primary care, and excluding 129 (2.5 % ) patients whose date of diagnosis was concurrent with death, we established an incident study cohort of 5,118 people diagnosed with cirrhosis during the observation period.
Patient characteristics
In the cohort of 5,118 patients, with a mean age of 59.3 (s.d. = 14.3) years, there were slightly more men (57.9 % ) than women, and just over half of the population had alcoholic cirrhosis (53.9 % ). Median follow-up was 1.88 (interquartile range: 0.40 -4.27) years. Just over half of the study population (56.3 % ) had compensated cirrhosis (Baveno IV stages 1 or 2) at diagnosis. Th e following patients had non-alcohol etiology: 574 (11.2 % ) chronic viral hepatitis, 362 (7.1 % ) autoimmune disease, 143 (2.8 % ) metabolic disease, and 1,283 (25.1 % ) cryptogenic cirrhosis. Numbers in the autoimmune and metabolic disease categories were combined for all subsequent analyses.
Incidence
Over the 12-year period, crude incidence was 30.7 cases per 100,000 person-years, increasing from 24.6 in 1998 to 38.4 per 100,000 person-years in 2009 ( Table 1 ) . Th is increase fi tted a continuous model with an average yearly IRR of 1.04 (95 % confi dence interval (CI) 1.03 -1.05) adjusted for age and sex, corresponding to a 50.6 % increase over the time studied. Incidence was about 50 % higher in men than women, 36.2 cases per 100,000 personyears and 25.4 cases per 100,000 person-years, respectively, IRR 1.50 (95 % CI 1.42 -1.58) adjusted for age and year of diagnosis; Figure 1 ). Adjusted IRRs are shown in Table 1 .
Etiology
A higher proportion of men than women had alcoholic cirrhosis, 61.9 % vs.42.8 % , respectively, ( P < 0.001) and the distribution of etiology varied by age ( P < 0.001). For men, a larger proportion of the younger patients had alcoholic cirrhosis. For women, twice as many had cryptogenic cirrhosis, compared with men, in the younger age-groups and approximately four times as many had cryptogenic compared with alcoholic cirrhosis in those older than 75 years ( Table 2 ) .
Between 1998 and 2009, adjusting for age, statistically signifi cant increases in the incidence of both alcoholic and non-alcoholic cirrhosis were seen in men, 40 % (95 % CI 10 -80 % ) and 79 % (95 % CI 29.6 -147 % ), respectively, and in women, a 52.5 % (95 % CI 4.6 -122.4 % ) increase was seen in those with alcoholic cirrhosis and a 48.3 % increase (95 % CI 8.6 -102.6 % ) in those with non-alcoholrelated cirrhosis. Figures 2 and 3 show the trends over time for each type of etiology, for men and women, respectively. Th ere was a consistently higher proportion of men with alcoholic cirrhosis than with non-alcohol-related etiology. Th e converse was true for women. In cases with cryptogenic cirrhosis, in particular, there was a 1.7-fold (IRR 1.69, 95 % CI 1.10, 2.60) increase in incidence in men and a 2.5-fold (IRR 2.52, 95 % CI 1.57 -4.05) increase in incidence in women, adjusted for age.
Comparison with cancer
We estimated that 10,703 and 6,982 cirrhosis cases were newly diagnosed in men and women, respectively, in the United Kingdom in 2009. Figure 4 shows that our estimated number of cirrhosis cases was greater than that of the fi ft h most common cancer, non-Hodgkin ' s lymphoma, for both men and women. Th ere was a 52.4 % increase in European age-standardized incidence rates of cirrhosis incidence in males comparing the period 1998 -2000 and 2007 -2009. For women, the percentage increase was 38.3 % . Th e increase in incident cirrhosis was greater than all cancers apart from malignant melanoma and thyroid, (the latter for women only). Supplementary Figures 1 and 2 show how these percentage changes compare with the 20 most commonly diagnosed cancers in the United Kingdom for the same period.
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Validation of case defi nition
Of the 2,975 people identifi ed as incident cirrhosis cases in primary-care records during the study period, 2,230 (75 % ) had a hospital admission related to liver disease. Ten patients had a cirrhosis code in secondary care in 1997 so were excluded.
Of the 2,282 patients who had a cirrhosis diagnosis in secondary care only during the study period, and no cirrhosis diagnostic Read code in primary care, 2,062 (90.3 % ) had either death or additional evidence related to liver disease in their records, or a confi rmation of a cirrhosis diagnosis in their free text.
DISCUSSION
We found a 50.6 % increase in incidence of cirrhosis in England between 1998 and 2009. Over this period, cirrhosis occurred more commonly and at younger ages in men than women. A signifi cant increase in both alcoholic and non-alcoholic-related cirrhosis was seen for men and women across the period under study. In women, there was a signifi cant increase specifi cally in cryptogenic cirrhosis. We estimate that, over the age of 18, approximately 17,000 people were newly diagnosed with cirrhosis in 2009 in the United Kingdom. In comparison with the 
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Strengths and limitations
Th is is the fi rst population-based study using linked primary and secondary health-care data to establish a comprehensive cohort to measure the occurrence of cirrhosis in England. Given that, using one data source alone does not capture all incident cases of cirrhosis, we are confi dent that our estimates of incidence are more accurate than has been determined previously, including those provided in own previous work ( 5 ). To be able to widely generalize our fi ndings, we need to be confi dent that the population we have studied is truly representative of all patients with cirrhosis. Given that patients in HES-linked practices are representative of the whole CPRD population and the latter is broadly similar in terms of demographics to that of England, we believe we have a representative population ( 10, 16 ) . Our defi nition of cirrhosis in secondary care, compared with that used by other studies, which included codes for chronic hepatitis and alcoholic liver disease ( 4, 17 ) , ensures that we are only including patients who have good evidence of cirrhosis. Although we have assigned a diagnosis date as the incident date of disease in our study (so as to be able to calculate rates of occurrence from a defi ned denominator), we appreciate that given the long sojourn time for cirrhosis to develop this will not be the onset of disease. However, this is analogous to the situation for most cancers meaning that our comparisons of incidence are on the same footing. Despite the possibility that the rise in diagnoses could refl ect better ascertainment rather than a true rise in the number of people acquiring the disease, (mediated by, e.g., an increase in diagnostic endoscopy or exploratory ultrasound), our fi gures refl ect the increase in the number of people subsequently treated with cirrhosis and a more accurate representation of the health-care burden this disease places on the health system than has previously been available. Th ere are oft en questions raised about the validity of coding seen in both primary-and secondary-care data ( 18, 19, 20 ) but in most studies that have validated recording of chronic disease accuracy has been high ( 21, 22 ) . A limitation of the HES data is that they cannot be directly validated against medical records because of the anonymization process used. However, a recent government audit found 91 % median accuracy in clinical coding of diagnoses and procedures ( 23 ) . Th e linked data in our study have improved our case defi nitions by providing supporting evidence of liver disease among the various health-care records.
Finally, we identifi ed a record of alcohol use consistent with it being the underlying etiology of disease in just over 50 % of the patients. Th is is almost identical to that found by Saunders et al. 
Other studies
A summary of the fi ndings of selected, large, population-based previous studies are presented in Table 3 . Although not exhaustive, this table allows us to provide a context for our results in comparison with studies that are broadly similar in scope and nature to ours. Our study is best compared with the two largest previous studies estimating incidence of liver cirrhosis in the United Kingdom ( 5, 7 ) . Th e study by Saunders et al. identifi ed one-tenth the size of our study population in the West Midlands using hospital and death registry data and reported an increase in incidence from 5.6 to 15.3 per 100,000 person-years during the period 1959 -1976. Our group ' s previous study that used solely primary-care data found a 45 % increase in incidence from 1992 to 2002, from 12 to 17 per 100,000 person-years. Our overall estimate of incidence of 30 per 100,000 person-years is higher than both these studies, which is unsurprising given that Saunders et al. ' s study was carried out more than 50 years ago and the study by Fleming et al. most probably underestimated the burden of disease because of not marked increase in the occurrence of liver disease in the United Kingdom ( 34 ) . Our use of population-based, routinely available, linked electronic health records has allowed us to show that the incidence of cirrhosis has increased more than that of the top four cancers during the period 1998 to 2009 in England. According to Cancer Research UK ' s predictions, overall cancer death rates are expected to fall by 17 % by 2030 in the United Kingdom ( 35 ) . Th is is in stark contrast to that predicted for alcohol-related liver deaths and implied both by our incidence fi gures and by the rising mortality rates recently reported ( 3, 36 ) . We have demonstrated how electronic routine health-care databases could fi ll the gap that currently exists given that the United Kingdom has no registry to monitor the occurrence of cirrhosis, which is escalating at an alarming rate. In addition to fi lling this gap, using electronic routine databases will help answer other research questions such as the regional variation of the disease and implications on cost and optimization of health-care resource allocation.
Conclusion
Cirrhosis represents a serious and growing burden of morbidity and mortality across England, for all etiologies and for both men and women. Our study is the fi rst to establish a comprehensive, representative sample of people with cirrhosis using population-based data analogous to cancer registries in England therefore allowing a direct comparison to be made with the incidence of cancer. Th e etiology of cirrhosis encompasses many preventable exposures such as chronic viral hepatitis, alcohol consumption, and the causes of obesity; therefore it is crucial to be able to count the number of newly occurring diagnoses of this disease over time in a reproducible manner. Th is will allow one to assess the impact of both individual-and population-level interventions on the occurrence of this disease. Given the continued rise in cirrhosis that we have described, greater than that seen for almost all of the most commonly diagnosed cancers in the United Kingdom, it is imperative that strategies are put in place to monitor the trends in this disease more closely.
having access to linked secondary-care data. However, the rate of change we describe is almost identical to that of the latter study. In comparison with some studies conducted in Denmark, one used both in and outpatients during 1996 -2006 and therefore had a comprehensive cohort similar to ours ( 27 ) . Th eir overall incidence fi ndings were similar to ours, however, the authors did not look at trends over time nor make a comparison between the diff erent types of etiology. In contrast to our fi ndings, the other Danish study found no discernable trend in incidence of alcoholic cirrhosis during the study period, 1995 -2006 ( 25 ) . Although there has been an increase in alcohol consumption in the United Kingdom over the last 20 years ( 28 ), our study also shows that there has been a concurrent rise in the number of people with non-alcohol cirrhosis. In particular, we have reported a substantial increase in those with cryptogenic cirrhosis. Many cases of cryptogenic cirrhosis are likely to be end stage non-alcoholic steatohepatitis encompassed within the spectrum of non-alcohol fatty liver disease ( 29 ) . Obesity is linked to non-alcohol fatty liver disease ( 30 ) , and the increase in the incidence of cryptogenic cirrhosis we report may refl ect the increase in obesity seen in the United Kingdom over the last few decades ( 31 ). With respect to the association between age and etiology, a recent study has shown that cryptogenic cirrhosis is the etiology of the elderly, similar to our fi ndings, as non-alcoholic steatohepatitis was more common among elderly patients compared with non-elderly ones ( 32 ) .
Comparison with cancer
In England, more than one in three people will develop cancer at some stage in their lives ( 33 ) . In the year 2000, the British government established a NHS plan for cancer: a comprehensive strategy for bringing together prevention, screening, diagnosis, treatment, and care ( 33 ) . National registries have been set up in England over the last 80 years to monitor trends of incidence ( 2 ) . In contrast, no services for monitoring and detecting cirrhosis have been provided despite the fact that in 2001 the Chief Medical Offi cer reported a 
